Journal of Epidemiology and Global Health,
Journal Year:
2024,
Volume and Issue:
14(3), P. 645 - 657
Published: Aug. 14, 2024
Abstract
The
last
decade
has
seen
major
advances
and
growth
in
internet-based
surveillance
for
infectious
diseases
through
advanced
computational
capacity,
growing
adoption
of
smart
devices,
increased
availability
Artificial
Intelligence
(AI),
alongside
environmental
pressures
including
climate
land
use
change
contributing
to
threat
spread
pandemics
emerging
diseases.
With
the
increasing
burden
COVID-19
pandemic,
need
developing
novel
technologies
integrating
data
approaches
improving
disease
is
greater
than
ever.
In
this
systematic
review,
we
searched
scientific
literature
research
on
or
digital
influenza,
dengue
fever
from
2013
2023.
We
have
provided
an
overview
recent
(EID),
describing
changes
landscape,
with
recommendations
future
directed
at
public
health
policymakers,
healthcare
providers,
government
departments
enhance
traditional
detecting,
monitoring,
reporting,
responding
dengue,
COVID-19.
Journal of Clinical Microbiology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 17, 2024
ABSTRACT
The
European
Committee
on
Antimicrobial
Susceptibility
Testing
(EUCAST)
recommends
two
steps
for
detecting
beta-lactamases
in
Gram-negative
bacteria.
Screening
potential
extended-spectrum
beta-lactamase
(ESBL),
plasmid-mediated
AmpC
beta-lactamase,
or
carbapenemase
production
is
confirmed.
We
aimed
to
validate
generative
pre-trained
transformer
(GPT)-4
and
GPT-agent
pre-classification
of
disk
diffusion
indicate
beta-lactamases.
assigned
225
isolates
based
phenotypic
resistances
against
beta-lactam
antibiotics
additional
tests
one
more
resistance
mechanisms
as
follows:
“none,”
“ESBL,”
“AmpC,”
“carbapenemase.”
Next,
we
customized
a
with
EUCAST
guidelines
breakpoint
table
(v13.1).
compared
routine
diagnostics
(reference)
those
(i)
EUCAST-GPT-expert,
(ii)
microbiologists,
(iii)
non-customized
GPT-4.
determined
sensitivities
specificities
flag
suspect
resistances.
Three
microbiologists
showed
concordance
814/862
(94.4%)
categories
were
used
median
eight
words
(interquartile
range
[IQR]
4–11)
reasoning.
Median
sensitivity/specificity
ESBL,
AmpC,
98%/99.1%,
96.8%/97.1%,
95.5%/98.5%,
respectively.
prompts
EUCAST-GPT-expert
706/862
(81.9%)
but
158
(IQR
140–174)
Sensitivity/specificity
prediction
95.4%/69.23%,
96.9%/86.3%,
100%/98.8%,
Non-customized
GPT-4
could
interpret
169/862
(19.6%)
categories,
137/169
(81.1%)
agreed
diagnostics.
was
85
72–105)
Microbiologists
higher
shorter
argumentations
GPT-agents.
Humans
GPT-agent’s
unspecific
flagging
ESBL
potentially
results
testing,
diagnostic
delays,
costs.
not
approved
by
regulatory
bodies,
validation
large
language
models
needed.
IMPORTANCE
study
titled
"GPT-4-based
AI
agents—the
new
expert
system
detection
antimicrobial
mechanisms?"
critically
important
it
explores
the
integration
advanced
artificial
intelligence
(AI)
technologies,
like
(GPT)-4,
into
field
laboratory
medicine,
specifically
(AMR).
With
growing
challenge
AMR,
there
pressing
need
innovative
solutions
that
can
enhance
accuracy
efficiency.
This
research
assesses
capability
support
existing
two-step
confirmatory
process
recommended
By
speeding
up
improving
precision
initial
screenings,
reduce
time
appropriate
treatment
interventions.
Furthermore,
this
vital
validating
reliability
safety
tools
clinical
settings,
ensuring
they
meet
stringent
standards
before
be
broadly
implemented.
herald
significant
shift
how
are
performed,
ultimately
leading
better
patient
outcomes.
ACM Transactions on Management Information Systems,
Journal Year:
2024,
Volume and Issue:
16(1), P. 1 - 26
Published: Oct. 22, 2024
The
global
rise
in
mental
disorders,
particularly
workplaces,
necessitated
innovative
and
scalable
solutions
for
delivering
therapy.
Large
Language
Model
(LLM)-based
health
chatbots
have
rapidly
emerged
as
a
promising
tool
overcoming
the
time,
cost,
accessibility
constraints
often
associated
with
traditional
However,
LLM-based
are
their
nascency,
significant
opportunities
to
enhance
capabilities
operate
within
organizational
contexts.
To
this
end,
research
seeks
examine
role
development
of
LLMs
over
past
half-decade.
Through
our
review,
we
identified
50
health-related
chatbots,
including
22
models
targeting
general
health,
depression,
anxiety,
stress,
suicide
ideation.
These
primarily
used
emotional
support
guidance
but
lack
specifically
designed
workplace
where
such
issues
increasingly
prevalent.
review
covers
development,
applications,
evaluation,
ethical
concerns,
integration
services,
LLM-as-a-Service,
various
other
business
implications
settings.
We
provide
illustration
how
approaches
could
overcome
limitations
also
offer
system
that
help
facilitate
systematic
evaluation
chatbots.
suggestions
future
tailored
needs.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 20, 2024
The
performance
of
two
artificial
intelligence
(AI)
platforms,
ChatGPT
3.5
(OpenAI,
California,
United
States)
and
Gemini
(Google
AI,
was
assessed
by
answering
200
questions
microbiology
drawn
from
validated
sources.
were
selected
topics
such
as
General
Microbiology,
Immunology,
Microbiology
Applied
to
Infectious
Diseases.
study
conducted
December
2023
March
2024,
the
responses
different
AI
platforms
compared
with
an
answer
key.
Statistical
analysis
performed
assess
accuracy.
had
comparable
accuracy
correct
response
scores
71%
70.5%,
respectively.
Their
varied
across
sections.
better
in
a
score
section.
study's
findings
highlight
that
can
be
utilized
medical
education.
evolution
continuous
updating
are
required
improve
their
performance.
Journal of Epidemiology and Global Health,
Journal Year:
2024,
Volume and Issue:
14(3), P. 645 - 657
Published: Aug. 14, 2024
Abstract
The
last
decade
has
seen
major
advances
and
growth
in
internet-based
surveillance
for
infectious
diseases
through
advanced
computational
capacity,
growing
adoption
of
smart
devices,
increased
availability
Artificial
Intelligence
(AI),
alongside
environmental
pressures
including
climate
land
use
change
contributing
to
threat
spread
pandemics
emerging
diseases.
With
the
increasing
burden
COVID-19
pandemic,
need
developing
novel
technologies
integrating
data
approaches
improving
disease
is
greater
than
ever.
In
this
systematic
review,
we
searched
scientific
literature
research
on
or
digital
influenza,
dengue
fever
from
2013
2023.
We
have
provided
an
overview
recent
(EID),
describing
changes
landscape,
with
recommendations
future
directed
at
public
health
policymakers,
healthcare
providers,
government
departments
enhance
traditional
detecting,
monitoring,
reporting,
responding
dengue,
COVID-19.